Fairer Finance (FF) is a consultancy launched in 2014, on a mission to become the UK's most trusted provider of consumer financial services ratings. FF makes money through four key channels namely, licensing access to its data and insights, selling endorsements to those who do well in its ratings, sponsored research that helps improve the financial services market, and helping firms do better for their customers. FF earned £170,000 worth of revenues in its latest quarter, had its ratings published on thetimes.co.uk, which got 35 million views/week and onboarded noted entity, Lloyds Bank, that uses FF's data insights. The company aims to expand into more banking and insurance sectors and grow its consumer presence, helping it to strike deals with comparison sites and sign up more companies for its Insight services. The company will use the investment to expand its campaigning work and create a fairer market for consumers.
days to go:
Expired
investment:
£291,899
Active Needle Technology offers an award-winning "needle actuating device" which has high value medical and consumer applications. The company's patent-pending proprietary ultrasonic technology enhances visibility for medical needles in applications such as biopsy, in regional and joint anaesthesia and others. The company aims to commercialise its technology into a $4+ billion special purpose needle market. After identifying obvious commercial advantages in the tattoo market, Active Needle plans to use its ultrasonic needle technology to develop a low-pain tattooing system. Moreover, the company has won an Innovate UK grant to develop and test the tattoo device. With the proceeds, the company will complete CE marking for its initial biopsy device, for development of anaesthesia and tattooing products.
days to go:
Expired
investment:
£194,100
Over the past 8 years, Advatech Healthcare has created Hippo, a proven disabled and non-emergency patients transportation services (NEPTS) in the Essex area. Due to its dependability and efficiency, Hippo is now poised to become the UK's best national wheelchair accessible healthcare services on a wearable technology platform. According to the Office for Technology Statistics data, there are 13.37 million people disabled in the UK who lack dedicated non-emergency transportation. Hippo could save the National Health Service (NHS) up to 60% on transportation costs increasing faster hospital bed rotation and providing dedicated transportation for disabled and non-emergency patients with a medically trained staff. It also offers medical and technological necessities not offered by many leading operators. Currently, the company operates within the Essex area. By the end of 2020, the company aims to commence seven new contracts it has signed with the NHS. It also signed a deal with Cambridge Adult Social Care that is expected to close, within a 5-year term and generate over £200,000 per year.
days to go:
Expired
investment:
Withheld
The Pension Lab offers an interative platform for employees and individuals, helping them reconnect and engage with their pensions. Its mission is to provide the customers with better knowledge of pensions and promote long-term financial decision making. The company has reached the finals of 'Pitchfest' competition held at the NEC as a component of “Venturefest”, and it is also a finalist in the “Innovation in Business” category. Some of the best Fintech solutions providers and pension services such as Yodlee and Origo are in partnership with the Pension Lab. With the proceeds, the company will develop its working capital, infrastructure development, and customer acquisition.
days to go:
Expired
investment:
£38,024
Thyngs is a touch-free instant payment platform for businesses and charities. It has around 20 active re-seller partners for new sectors and markets. The company is working with PricewaterhouseCoopers (PwC) as part of its raise programme and actively engaging with several Series A Venture Capitalist (VC) funds intending to raise £4-5 million in late 2021 to scale its business. Thyngs aggregates various payment partners including PayPal, Worldpay, Apple Pay and Google Pay. The company was the cashless donation platform for 210,000 fundraising events for Macmillan's 'World's Biggest Coffee Morning', which raised £27 million in 2019. Many reputed organisations such as Warner Bros, Royal British Legion, Wasabi, National Geographic, and ANZ Bank are working with Thyngs. The company will use the investment to enhance its marketing campaign, bolster its sales team, work on data security and integrations on its platform, and expand the account management team to boost its business.
days to go:
Expired
investment:
£329,591
Evaclite manufactures dynamic exit signs designed to make buildings safer and save lives. The company argues that its products are 77% more visible than conventional exit signs and reduces congestion at exits by 36%. The company received the 2018 FIREX - Fire Innovation of the Year Award. It also won the Safety and Health Excellence (SHE) Award in 2019 and 2020. Evaclite counts companies like Apple, CBRE, BBC, Melia, and MetroBank amongst its clients. The company has inquiries from over a dozen countries globally with a 12-month sales opportunity pipeline of over £1.5 million. It will use 60% of the investment to build its sales team, 28% to boost its inbound marketing campaign, 7% to develop additional intellectual property, and 5% towards overhead and general costs.
days to go:
Expired
investment:
£148,736
Luas Diagnostics (LD) aims to develop and market easy-to-use, rapid and accurate diagnostics tests with the aim of deploying these tests in remote settings away from centralised testing laboratories. The company has signed an exclusive distribution agreement with Chembio Diagnostics Systems (CDS) in the USA to market its Covid-19 antibody and antigen tests in the UK and Ireland. It has also signed a Memorandum of Understanding (MoU) with the University of Birmingham to develop saliva-based, rapid Covid-19 tests. LD is also working on coming up with a therapeutic drug monitoring system based on the same technology used worldwide to test people with diabetes for glucose levels in the blood. The company is developing the system so that it can be used at home, in pharmacies or GP surgery. The first product will test for Theophylline which is used to treat Chronic Obstructive Pulmonary Disease (COPD). LD will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
£326,190
Podcast Radio (PR) is the Ofcom-licensed UK digital broadcast radio station showcasing podcasts 24/7 globally. It is currently broadcasting in Surrey, Manchester, London, and Glasgow. Podcasting is expected to become a $3.3 billion industry by 2025. PR aims to be a disruptor in this segment. PR got front-page coverage in the international edition of Radio World magazine and has onboarded US radio Disc Jockey (DJ) Gene Baxter. The company will use 15% of the investment to secure digital radio broadcast transmission in 5 more UK cities by the end of 2020, 15% to partner with applicants for new digital radio transmitters, 15% to create a PR-led UK marketing campaign supported by social media, 25% to recruit new staff members, 10% to develop its on-air content, 10% to develop its website and application, and 10% to build new business partnerships to drive the international expansion of the company.
days to go:
Expired
investment:
£149,023
Glint is a proprietary multi-currency platform that allows users to buy, save, spend and send real gold and other currencies, digitally with its application. The company asserts that its scalable technology enables its clients to use their currencies such as GBP, USD, EUR and Gold, with Glint's UK, EU and US-issued Mastercards in 210 countries worldwide. Glint also points out that its Peer-to-Peer (P2P) Service, Glint It!, allows clients to send and receive gold and currency between Glint accounts in over 160 countries. The company has raised £20 million in equity funding to date, reached 79,000 registered clients, and overseen over £158 million worth of transactions on its platform. Glint will use the investment to maximise revenue, organically grow its business, increase its registered customer base to 250,000 in 2021, and hire key personnel across various portfolios.
days to go:
Expired
investment:
£3,072,539
Avida Global (AG) is a Business-to-Business (B2B) producer of high-quality medicinal cannabis oils and derivatives for the global medical, well-being and cosmeceutical markets. The company has a cultivation and processing facility in North-East Colombia. It asserts that the therapeutic properties of the cannabis plant has driven 53 countries to legalise its use, with more to follow. AG seeks to capture this demand and become a contender in the medicinal cannabis market that is expected to soar from $33.1 billion to $84.0 billion by 2028. The company has received regulatory approvals for initial non-psychoactive cannabis cultivation, manufacturing, and export licences in 2019. It is working on a partnership with a medicinal cannabis prescriber through doctors and clinics for the supply of medicinal cannabis strains in the UK. The company will use 40% of the investment to drive revenue growth, 25% as capital expenses, and 35% as additional operating expenses.
days to go:
Expired
investment:
£1,646,249
